Safety and efficacy of siponimod (BAF312) in patients with relapsing-remitting multiple sclerosis dose-blinded, randomized extension of the phase 2BOLDStudy

MS Treatments

Jahr

Publikationsjahr
2016

Autoren

Autorenliste der Publikation
Kappos L, Li DK, Stüve O, Hartung HP, Freedman MS, Hemmer B, Rieckmann P, Montalban X, Ziemssen T, Hunter B, Arnould S, Wallström E, Selmaj K.

Verlag

Publisher-Information
JAMA Neurol. 2016 Sep 1;73(9):1089-98.

Link

Zur Publikation (externer Server)
https://doi.org/10.1001/jamaneurol.2016.1451

Tags

Forschungsthemen
Multiple SkleroseMS Behandlung
Treatments2016